Pelvic Electro-Stimulators Market Size, Share and Global Trend By Product (Mobile, Fixed), End Users (Clinics, Hospitals) and Regional Forecast, 2024-2032

Electrical Stimulation is a modern, convenient therapy in the treatment of urinary stress incontinence as well as in the strengthening of weak pelvic floor muscles. By electro-stimulators, a low-grade electrical impulse is transmitted to the nerve that supplies the pelvic muscles which cause a muscle contraction and thus helps in stopping the urge for urination. These pulses are not painful but require a long time exposure to get positive effects. There are different types of electro-stimulation such as electrical muscle stimulation (EMS), Neuromuscular Electrical Stimulation (NMES), Transcutaneous Electrical Nerve Stimulation (TENS) and Others. According to the American Urological Association, around 33 million people in the U.S suffer from urinary urgency, frequency, and incontinence. Electro-stimulators offer a lucrative market opportunity during the forecast period owing to its effectiveness and growing acceptance across the globe.

Extensive research and development activities in pelvic electro-stimulators to bring out robust therapies in the market for the treatment of weak pelvic floor muscles as well as in the treatment of stress urinary incontinence which is likely to boost the growth of the global pelvic electro-stimulators market. Also, high investment by the manufacturers as well as growing mergers and acquisitions among the players operating in the pelvic electro-stimulators market are also likely to drive the market during the forecast period.

On the other side, the side effects caused due to constant use of the electro-stimulators can hamper the growth of the pelvic electro-stimulators market.

Key Players Covered:

Leading manufacturers in the pelvic electro-stimulators market are Atlantic Therapeutics, ActivLife Technologies, InControl Medical, LLC, Everyway Medical Instruments Co., Ltd, Laborie, Zynex Medical, The Prometheus Group, Shenzhen XFT Medical Limited, and Others.

SEGMENTATION

Mobile Pelvic electro-stimulators are widely used and are in demand due to its convenience as they are small, portable and are having positive therapeutic effects. The market of mobile pelvic electro-stimulators is likely to increase in the forecast period due to advancements in the system by aiming the comfort of the patient.

Key Insights

• Overview of the pricing analysis of pelvic electro-stimulators in the market


• Overview of the other therapy threats against pelvic electro-stimulation therapy


• Overview of the technological advancements in the pelvic electro-stimulators


• Key mergers and acquisitions

Regional Analysis:

Among the regions, the pelvic electro-stimulators market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the market due to the presence of strong players in the manufacturing of the electro-stimulators as well as an increasing number of acquisitions. Also, Europe is likely to show significant growth during the forecast period due to increasing incidences of urinary incontinence. The Asia Pacific is estimated to show a higher growth rate during the forecast period due to increase in the adoption of advanced technologies of the pelvic electro-stimulators due to a surge in the economy, growing incidence rates of pelvic disorders, and also due to increasing mergers and acquisitions among the leading players of the pelvic electro-stimulators market.

Key Industry Developments

• In March 2019, InControl Medical, LLC, has received a U.S.FDA nod for its ATTAIN – over-the-counter, non-implantable pelvic muscle stimulator to treat women suffering from bladder or bowel leakage having 90% effectiveness.


• In November 2018, Atlantic Therapeutics, LLC, received U.S.FDA approval for its INNOVO, transcutaneous electric stimulator, non-invasive having a multipath technology that comfortably, safely and effortlessly strengthens the pelvic floor muscles.


• In March 2017, ActivLife Technologies Pty Ltd., launched a wearable TENS (Transcutaneous Electrical Nerve Stimulation) in a form of a belt to increase the comfort of the patient.